Quanterix Corporation (QTRX)
| Market Cap | 1.71B |
| Revenue (ttm) | 97.86M |
| Net Income (ttm) | -30.02M |
| Shares Out | 36.33M |
| EPS (ttm) | -0.97 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $46.96 |
| Previous Close | $56.10 |
| Change ($) | -9.14 |
| Change (%) | -16.29% |
| Day's Open | 54.79 |
| Day's Range | 46.57 - 56.25 |
| Day's Volume | 556,467 |
| 52-Week Range | 23.87 - 92.57 |
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fina...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the appointme...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced a webinar with leading industr...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has a...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Simoa® technology has...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its ultra-sensitive Simoa...
Since going public just over three years ago, Quanterix Corp. (NASDAQ:QTRX) shares have quadrupled to about $63. Recently, the Billerica, Massachusetts-based diagnostics company closed another public of...
Quanterix Corporation (QTRX) delivered earnings and revenue surprises of -3.33% and 3.09%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the fou...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executive...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fina...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executiv...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agreem...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previously...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its previously...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has commenced an unde...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Executive Off...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today provided operational and preliminary fi...
Shares of Quanterix Corp. rallied nearly 10% in the extended session Monday after the life-sciences company said the Food and Drug Administration has issued an emergency use authorization for the compan...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Adminis...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, Chief Exec...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Admini...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Appoints William Geist as Chief Operating Officer
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Executive Off...
Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call Transcript
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, Chief Exec...
Quanterix: Still Bullish But Valuation Less Compelling
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exc...
Quanterix's industry leading platform, which is highly levered to the growth in precision medicine, can detect protein biomarkers at significantly lower concentrations and at higher sensitivity vs compe...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previously...
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2020 Results - Earnings Call Transcript
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2020 Results - Earnings Call Transcript
Quanterix (QTRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2019 Results - Earnings Call Transcript
Quanterix Corp (QTRX) CEO Kevin Hrusovsky on Q3 2019 Results - Earnings Call Transcript
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2019 Results - Earnings Call Transcript
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2019 Results - Earnings Call Transcript
About QTRX
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on... [Read more...]
| Industry Medical Devices | IPO Date Dec 7, 2017 |
| Stock Exchange NASDAQ | Ticker Symbol QTRX |
Financial Performance
In 2020, Quanterix's revenue was $86.38 million, an increase of 52.25% compared to the previous year's $56.73 million. Losses were -$31.53 million, -22.71% less than in 2019.
Analyst Forecasts
According to 5 analysts, the average rating for Quanterix stock is "Strong Buy." The 12-month stock price forecast is 84.00, which is an increase of 78.88% from the latest price.